ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710416 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710416; 2) Community: the network communities that were significantly associated with the response to NSC 710416; 3) Molecule: the relationships between components within communities and NSC 710416; 4) MDR: the compounds that were significantly associated with the NSC 710416.

NSC Compound Enrichment Correlation
NSC 734799 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.0237952199154256 0.22496392
NSC 744165 Null 0.0237952199154256 0.082232124
NSC 752331 (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0246753314031135 0.28074369
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0246753314031139 0.42987975
NSC 634471 Null 0.0246753314031139 0.35763337
NSC 10520 Null 0.0252510646170343 -0.22114142
NSC 287459 Cytarabine AY 0.0252510646170343 0.4008465
NSC 58903 Null 0.0252510646170343 0.41216293
NSC 629676 N-Benzyl-2(R)-hydroxymethyl-3(R),4(R),5(S)- tribenzyloxypiperidine 0.0252510646170343 0.014176228
NSC 681638 Camptothecin Derivative 0.0252510646170343 0.30899848
Total:51  Current:24    [First] [Prev] [Next] [Last]